Inhibitor Therapeutics (INTI) Prepaid Assets (2013 - 2026)
Inhibitor Therapeutics' Prepaid Assets came in at $71,048 for Q2 2026, down 22.8% from $92,025 a year earlier and down 16.4% from the prior quarter.
Analysis
Inhibitor Therapeutics (INTI) Prepaid Assets (2013 - 2026) Analysis & Trends
At the end of FY2025, Inhibitor Therapeutics' Prepaid Assets was $71,507, down 18.6% from FY2024.
- Prepaid Assets carries a five-year compound annual growth rate of 17.2% (FY2020 to FY2025).
- Going back by year, Prepaid Assets was $87,795 in FY2024 (-19.6%), $109,243 in FY2023 (+357.1%), $23,900 in FY2022 (-15.1%) and $28,158 in FY2021 (-12.8%).
- The Q2 2026 figure represents the lowest quarterly Prepaid Assets since Q3 2023.
- Year-over-year, Prepaid Assets has declined for three consecutive quarters, with an average decline of 5.0% over the last eight quarters.
- The fastest year-over-year change in Prepaid Assets over five years came in Q3 2023 (growth of 596.6%), and the weakest in Q3 2022 (a decline of 72.7%).
- Business Quant data shows INTI's Prepaid Assets at $84,975 (Q1 2026), $71,507 (Q4 2025) and $87,428 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Inhibitor Therapeutics | 17.38 Mn | 17.38 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 71,048.00 |
| Mar 31, 2026 | 84,975.00 |
| Dec 31, 2025 | 71,507.00 |
| Sep 30, 2025 | 87,428.00 |
| Jun 30, 2025 | 92,025.00 |
| Mar 31, 2025 | 99,105.00 |
| Dec 31, 2024 | 87,795.00 |
| Sep 30, 2024 | 73,138.00 |
| Jun 30, 2024 | 74,625.00 |
| Mar 31, 2024 | 112,399.00 |
| Dec 31, 2023 | 109,243.00 |
| Sep 30, 2023 | 70,071.00 |
| Jun 30, 2023 | 58,007.00 |
| Mar 31, 2023 | 52,248.00 |
| Dec 31, 2022 | 23,900.00 |
| Sep 30, 2022 | 10,059.00 |
| Jun 30, 2022 | 13,572.00 |
| Mar 31, 2022 | 24,705.00 |
| Dec 31, 2021 | 28,158.00 |
| Sep 30, 2021 | 36,792.00 |
API Access
Inhibitor Therapeutics Prepaid Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=prepaid-assets&ticker=INTI&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "prepaid-assets", "ticker": "INTI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=prepaid-assets&ticker=INTI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();